Pancreatic Cancer Research

ResearcherWuxi People's HospitalActive in the last 2 years

Junying Xu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-6400-0606; OpenAlex author ID A5044285390, A5110186572. Sources: OpenAlex.

Their work

Papers
6 (first author 1, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
10
Papers, trials and grants by year

2013: 2 papers · 2014: none · 2015: none · 2016: none · 2017: none · 2018: none · 2019: 1 paper · 2020: none · 2021: none · 2022: 1 paper · 2023: 1 paper · 2024: none · 2025: none · 2026: 1 paper

Papers 6

  1. BCAT1-elicited branched-chain amino acid catabolism fosters neutrophil-mediated pan-metastasis in pancreatic cancer. Co-author DOI 10.1016/j.ymthe.2026.01.039↗
  2. PSMC2 is a Novel Prognostic Biomarker and Predicts Immunotherapeutic Responses: From Pancreatic Cancer to Pan-Cancer. Co-author DOI 10.2147/pgpm.s418533↗
  3. NEUROD1 predicts better prognosis in pancreatic cancer revealed by a TILs-based prognostic signature. Co-author DOI 10.3389/fphar.2022.1025921↗
  4. The Importance of a Conjoint Analysis of Tumor-Associated Macrophages and Immune Checkpoints in Pancreatic Cancer. Co-author DOI 10.1097/mpa.0000000000001364↗
  5. High level of FOXC1 expression is associated with poor prognosis in pancreatic ductal adenocarcinoma. Last author DOI 10.1007/s13277-012-0617-7↗
  6. M2-polarized tumor-associated macrophages promoted epithelial-mesenchymal transition in pancreatic cancer cells, partially through TLR4/IL-10 signaling pathway. First author DOI 10.1038/labinvest.2013.69↗

Closest collaborators

The 10 strongest of 10 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Junli Ding · 4 shared papers, 2013–2023 · strength 0.49
  2. Jie Mei · 2 shared papers, 2022–2023 · strength 0.34
  3. Chaoying Liu · 4 shared papers, 2013–2022 · strength 0.34
  4. Fan Xie · 1 shared paper, 2026 · strength 0.24
  5. Yuan Wei · 1 shared paper, 2026 · strength 0.24
  6. Xiang‐Ming Lao · 1 shared paper, 2026 · strength 0.24
  7. Wei Huang · 1 shared paper, 2023 · strength 0.19
  8. Zhiyang Jiang · 1 shared paper, 2022 · strength 0.15
  9. Rui Xu · 1 shared paper, 2022 · strength 0.15
  10. Lei Wang · 1 shared paper, 2013 · strength 0.04

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.